Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

Key Takeaways Novo Nordisk's U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Half a century of advancements in biomedical science paved the way for today’s powerful weight-loss drugs like Ozempic — so ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The ...

WITH all the buzz around the so-called ‘miracle’ weight-loss jabs Ozempic, you could easily mistake it for a cure for all. Although created to help manage type 2 diabetes the ...

Pharmaceutical giant Novo Nordisk (NVO) stock falls on Friday after receiving ... the company is looking to bring down the cost of its GLP-1 weight-loss injectables, Ozempic and Wegovy. For more ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Discounts of as much as half on the $1,000-plus-a-month injectables are meant to induce insurers to offer coverage to workers ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

I WAS treated by the oncology department in Hereford for my prostate cancer and the staff there were a pleasure to be treated ...